BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30830346)

  • 1. NIST lipidomics workflow questionnaire: an assessment of community-wide methodologies and perspectives.
    Bowden JA; Ulmer CZ; Jones CM; Koelmel JP; Yost RA
    Metabolomics; 2018 Mar; 14(5):53. PubMed ID: 30830346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonizing lipidomics: NIST interlaboratory comparison exercise for lipidomics using SRM 1950-Metabolites in Frozen Human Plasma.
    Bowden JA; Heckert A; Ulmer CZ; Jones CM; Koelmel JP; Abdullah L; Ahonen L; Alnouti Y; Armando AM; Asara JM; Bamba T; Barr JR; Bergquist J; Borchers CH; Brandsma J; Breitkopf SB; Cajka T; Cazenave-Gassiot A; Checa A; Cinel MA; Colas RA; Cremers S; Dennis EA; Evans JE; Fauland A; Fiehn O; Gardner MS; Garrett TJ; Gotlinger KH; Han J; Huang Y; Neo AH; Hyötyläinen T; Izumi Y; Jiang H; Jiang H; Jiang J; Kachman M; Kiyonami R; Klavins K; Klose C; Köfeler HC; Kolmert J; Koal T; Koster G; Kuklenyik Z; Kurland IJ; Leadley M; Lin K; Maddipati KR; McDougall D; Meikle PJ; Mellett NA; Monnin C; Moseley MA; Nandakumar R; Oresic M; Patterson R; Peake D; Pierce JS; Post M; Postle AD; Pugh R; Qiu Y; Quehenberger O; Ramrup P; Rees J; Rembiesa B; Reynaud D; Roth MR; Sales S; Schuhmann K; Schwartzman ML; Serhan CN; Shevchenko A; Somerville SE; St John-Williams L; Surma MA; Takeda H; Thakare R; Thompson JW; Torta F; Triebl A; Trötzmüller M; Ubhayasekera SJK; Vuckovic D; Weir JM; Welti R; Wenk MR; Wheelock CE; Yao L; Yuan M; Zhao XH; Zhou S
    J Lipid Res; 2017 Dec; 58(12):2275-2288. PubMed ID: 28986437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidomics, en route to accurate quantitation.
    Lam SM; Tian H; Shui G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):752-761. PubMed ID: 28216054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LipidQC: Method Validation Tool for Visual Comparison to SRM 1950 Using NIST Interlaboratory Comparison Exercise Lipid Consensus Mean Estimate Values.
    Ulmer CZ; Ragland JM; Koelmel JP; Heckert A; Jones CM; Garrett TJ; Yost RA; Bowden JA
    Anal Chem; 2017 Dec; 89(24):13069-13073. PubMed ID: 29148710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shared reference materials harmonize lipidomics across MS-based detection platforms and laboratories.
    Triebl A; Burla B; Selvalatchmanan J; Oh J; Tan SH; Chan MY; Mellet NA; Meikle PJ; Torta F; Wenk MR
    J Lipid Res; 2020 Jan; 61(1):105-115. PubMed ID: 31732502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC).
    Lippa KA; Aristizabal-Henao JJ; Beger RD; Bowden JA; Broeckling C; Beecher C; Clay Davis W; Dunn WB; Flores R; Goodacre R; Gouveia GJ; Harms AC; Hartung T; Jones CM; Lewis MR; Ntai I; Percy AJ; Raftery D; Schock TB; Sun J; Theodoridis G; Tayyari F; Torta F; Ulmer CZ; Wilson I; Ubhi BK
    Metabolomics; 2022 Apr; 18(4):24. PubMed ID: 35397018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive lipidomics of mouse plasma using class-specific surrogate calibrants and SWATH acquisition for large-scale lipid quantification in untargeted analysis.
    Drotleff B; Illison J; Schlotterbeck J; Lukowski R; Lämmerhofer M
    Anal Chim Acta; 2019 Dec; 1086():90-102. PubMed ID: 31561798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A normalized signal calibration with a long-term reference improves the robustness of RPLC-MRM/MS lipidomics in plasma.
    Babiy B; Busto R; Pastor Ó
    Anal Bioanal Chem; 2021 Jun; 413(15):4077-4090. PubMed ID: 33907864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners.
    Evans AM; O'Donovan C; Playdon M; Beecher C; Beger RD; Bowden JA; Broadhurst D; Clish CB; Dasari S; Dunn WB; Griffin JL; Hartung T; Hsu PC; Huan T; Jans J; Jones CM; Kachman M; Kleensang A; Lewis MR; Monge ME; Mosley JD; Taylor E; Tayyari F; Theodoridis G; Torta F; Ubhi BK; Vuckovic D;
    Metabolomics; 2020 Oct; 16(10):113. PubMed ID: 33044703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Efforts to Improve Lipid Stability during Sample Preparation and Standardization Efforts to Ensure Accuracy in the Reporting of Lipid Measurements.
    Ulmer CZ; Koelmel JP; Jones CM; Garrett TJ; Aristizabal-Henao JJ; Vesper HW; Bowden JA
    Lipids; 2021 Jan; 56(1):3-16. PubMed ID: 32519378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances towards mass spectrometry-based clinical lipidomics.
    Salihovic S; Lamichane S; Hyötyläinen T; Orešič M
    Curr Opin Chem Biol; 2023 Oct; 76():102370. PubMed ID: 37473482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of lipidomics data should be standardized.
    Liebisch G; Ekroos K; Hermansson M; Ejsing CS
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):747-751. PubMed ID: 28238863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Lipid Mass Spectrometry and Lipidomics.
    Zarini S; Barkley RM; Gijón MA; Murphy RC
    Methods Mol Biol; 2019; 1978():81-105. PubMed ID: 31119658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-Laboratory Standardization of Preclinical Lipidomics Using Differential Mobility Spectrometry and Multiple Reaction Monitoring.
    Ghorasaini M; Mohammed Y; Adamski J; Bettcher L; Bowden JA; Cabruja M; Contrepois K; Ellenberger M; Gajera B; Haid M; Hornburg D; Hunter C; Jones CM; Klein T; Mayboroda O; Mirzaian M; Moaddel R; Ferrucci L; Lovett J; Nazir K; Pearson M; Ubhi BK; Raftery D; Riols F; Sayers R; Sijbrands EJG; Snyder MP; Su B; Velagapudi V; Williams KJ; de Rijke YB; Giera M
    Anal Chem; 2021 Dec; 93(49):16369-16378. PubMed ID: 34859676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines.
    Burla B; Arita M; Arita M; Bendt AK; Cazenave-Gassiot A; Dennis EA; Ekroos K; Han X; Ikeda K; Liebisch G; Lin MK; Loh TP; Meikle PJ; Orešič M; Quehenberger O; Shevchenko A; Torta F; Wakelam MJO; Wheelock CE; Wenk MR
    J Lipid Res; 2018 Oct; 59(10):2001-2017. PubMed ID: 30115755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing the lipidomics workflow for clinical studies--practical considerations.
    Hyötyläinen T; Orešič M
    Anal Bioanal Chem; 2015 Jul; 407(17):4973-93. PubMed ID: 25855150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipidomics: Prospects from a technological perspective.
    Triebl A; Hartler J; Trötzmüller M; C Köfeler H
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):740-746. PubMed ID: 28341148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomics and Biomarker Discovery in Kidney Disease.
    Afshinnia F; Rajendiran TM; Wernisch S; Soni T; Jadoon A; Karnovsky A; Michailidis G; Pennathur S
    Semin Nephrol; 2018 Mar; 38(2):127-141. PubMed ID: 29602396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green light for lipid fingerprinting.
    Haslam RP; Feussner I
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Aug; 1862(8):782-785. PubMed ID: 28433643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for good practice in MS-based lipidomics.
    Köfeler HC; Ahrends R; Baker ES; Ekroos K; Han X; Hoffmann N; Holčapek M; Wenk MR; Liebisch G
    J Lipid Res; 2021; 62():100138. PubMed ID: 34662536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.